Technology

Chemotype Evolution rapidly evolves fragments into novel leads using an empirical, iterative, target-directed screening approach....learn more

Therapeutics

By combining innovation with safe, validated small molecules, Carmot is creating novel drugs to treat inflammation, cancer, and metabolic diseases

October 16, 2012

Carmot wins National Institute of Diabetes and Digestive and Kidney Diseases award to study drug leads with “biased agonism” for Class-B GPCRs

Carmot Therapeutics announced today that it has won a two year SBIR grant from The National Institute of Diabetes and Digestive and Kidney Diseases to characterize and develop molecules that can selectively activate different GPCR signaling pathways....more